WELL Health Technologies Corp. (TSE:WELL) Receives Average Rating of “Moderate Buy” from Analysts

WELL Health Technologies Corp. (TSE:WELL) has earned a consensus recommendation of “Moderate Buy” from the seven brokerages that are currently covering the firm, Marketbeat.com reports. Two investment analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. The average twelve-month price objective among brokerages that have issued ratings on the stock in the last year is C$6.97.

WELL has been the subject of a number of research analyst reports. CIBC upped their price target on shares of WELL Health Technologies from C$4.75 to C$5.00 in a research note on Friday, August 16th. Ventum Financial reduced their price target on shares of WELL Health Technologies from C$8.00 to C$7.00 and set a “buy” rating for the company in a research note on Tuesday.

WELL Health Technologies Trading Up 1.1 %

Shares of TSE:WELL opened at C$4.42 on Thursday. The company has a 50 day moving average of C$4.44 and a 200-day moving average of C$4.28. The firm has a market cap of C$1.10 billion, a P/E ratio of 7.75, a P/E/G ratio of -1.93 and a beta of 1.20. WELL Health Technologies has a twelve month low of C$3.41 and a twelve month high of C$5.05. The company has a current ratio of 1.25, a quick ratio of 1.02 and a debt-to-equity ratio of 41.57.

WELL Health Technologies Company Profile

WELL Health Technologies Corp. operates as a practitioner-focused digital healthcare company in Canada, the United States, and internationally. It provides omni-channel patient services and solutions to specific markets, such as provider staffing, anesthesia, gastrointestinal health, women's health, primary care, and mental healthcare.